Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R2VH
|
||||
| Former ID |
DIB018571
|
||||
| Drug Name |
2-oleoyl-LPA
|
||||
| Synonyms |
2-acyl-1LPA; 2Acyl-LPA
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [539953] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H41O7P
|
||||
| InChI |
InChI=1S/C21H41O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(23)28-20(18-22)19-27-29(24,25)26/h9-10,20,22H,2-8,11-19H2,1H3,(H2,24,25,26)/b10-9-
|
||||
| InChIKey |
ZOOLJLSXNRZLDH-KTKRTIGZSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Lysophosphatidic acid receptor Edg-2 | Target Info | Agonist | [525840] | |
| Lysophosphatidate-3 receptor | Target Info | Agonist | [525840] | ||
| LPA2 receptor | Target Info | Agonist | [525840] | ||
| G protein-coupled receptor 35 | Target Info | Agonist | [530825] | ||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| Pathway Interaction Database | LPA receptor mediated eventslysophospholipid_pathway:LPA receptor mediated events | ||||
| References | |||||
| Ref 525840 | Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett. 2000 Jul 28;478(1-2):159-65. | ||||
| Ref 530825 | GPR35 is a novel lysophosphatidic acid receptor. Biochem Biophys Res Commun. 2010 Apr 30;395(2):232-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.